Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01333943 · ClinicalTrials.gov registry record · NA

Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty

A NA study of Total Knee Arthroplasty, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT01333943: Completed NA study of Total Knee Arthroplasty, sponsored by Hospital for Special Surgery, New York.

NCT01333943 is a NA study of Total Knee Arthroplasty that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 94 participants, below the 292-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01333943, a NA study of Total Knee Arthroplasty, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

Currently, the regional anesthetic standard of care for total knee replacement surgery is combined spinal/epidural, with or without a femoral nerve block, or FNB. Lasting approximately 18 hours, the FNB works by numbing the femoral nerve (and its branches), which is the major nerve controlling the knee joint. The femoral nerve also provides movement and sensation. While this regional anesthetic technique offers significant postoperative pain relief, it is possible that it may cause muscle weakness and increase patients' recovery time. Hence there is a need for an alternative technique, one that may help minimize postoperative pain as effectively as the FNB, while not causing weakness of the quadriceps muscle. The saphenous nerve, a branch of the femoral nerve, provides sensation to the knee. Thus it is hypothesized that by "blocking" or anesthetizing the saphenous nerve with local anesthetic closer to where it branches off, the area around and below the knee will feel numb. Yet unlike with the FNB, the quadriceps muscle itself will still be able to function. Patients will be randomized to receive FNB or saphenous nerve block. Quadriceps strength will be tested using a dynamometer before surgery (baseline), 6-8 hours following anesthesia administration, and on postoperative days 1 and 2. It is hypothesized that patients who receive FNB will experience a 50% decrease in quadriceps strength compared to baseline.

Primary Outcome

Measurements were made by a handheld dynamometer while patients perform isometric exercises. Results are presented in kilogram-force (kgF) units. One kgF is equal to 9.80665 N.

Conditions Studied

Interventions

  • PROCEDURE Study Group: Experimental
  • PROCEDURE Control Group

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2011-03
Est. Completion 2011-11
Phase NA

What the finished NCT01333943 record still lists

NCT01333943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 292-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (68% lower).

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Study Group: Experimental is the first listed.

NCT01333943 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01333943 about?

NCT01333943 is a clinical study titled "Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty". Currently, the regional anesthetic standard of care for total knee replacement surgery is combined spinal/epidural, with or without a femoral nerve block, or FNB. Lasting approximately 18 hours, the FNB works by numbing the femoral nerve (and its branches), which is the major nerve controlling the k...

What is the current status of trial NCT01333943?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2011-03. Estimated completion is 2011-11.

What conditions does trial NCT01333943 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT01333943?

The interventions under investigation include: Study Group: Experimental (PROCEDURE), Control Group (PROCEDURE).

Who is sponsoring clinical trial NCT01333943?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01333943 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01333943's enrollment target sits among peer trials

94 19th of 29 higher than 11 of 29 other Total Knee Arthroplasty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01333943, the US trial registry maintained by the National Library of Medicine. NCT01333943 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.